Novanta (NOVT) to Announce Quarterly Earnings on Wednesday

Novanta (NASDAQ:NOVT) is expected to post its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $0.83 per share and revenue of $262.2980 million for the quarter. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:00 AM ET.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. The firm had revenue of $257.71 million during the quarter, compared to the consensus estimate of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The business’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.74 EPS. On average, analysts expect Novanta to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Performance

NASDAQ NOVT opened at $141.62 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. The firm has a market capitalization of $5.35 billion, a price-to-earnings ratio of 102.62 and a beta of 1.67. The company’s fifty day moving average is $155.30 and its two-hundred day moving average is $140.54. Novanta has a 52-week low of $98.27 and a 52-week high of $171.85.

Insider Transactions at Novanta

In other news, CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total value of $1,047,345.00. Following the completion of the transaction, the chief executive officer owned 29,761 shares in the company, valued at approximately $4,795,389.93. This represents a 17.93% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

Institutional Trading of Novanta

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Corient Private Wealth LLC bought a new stake in Novanta in the fourth quarter valued at about $275,000. Invesco Ltd. lifted its stake in Novanta by 9.0% during the fourth quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock worth $8,102,000 after purchasing an additional 5,600 shares during the period. Alberta Investment Management Corp acquired a new stake in Novanta during the fourth quarter valued at approximately $1,285,000. Mercer Global Advisors Inc. ADV acquired a new stake in Novanta during the fourth quarter valued at approximately $314,000. Finally, Empowered Funds LLC boosted its holdings in Novanta by 16.7% during the fourth quarter. Empowered Funds LLC now owns 7,888 shares of the technology company’s stock valued at $939,000 after purchasing an additional 1,128 shares in the last quarter. Institutional investors own 98.35% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on NOVT shares. Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Novanta presently has a consensus rating of “Hold” and an average target price of $180.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.